No SMAD4 Hypermethylation in Colorectal Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 2000 Sep 20

PMID 10993648

Citations 12

Authors

S Roth

P Laiho

R Salovaara

V Launonen

L A Aaltonen

Affiliations

Soon will be listed here.

Abstract

The chromosome region 18q21 is frequently deleted in colorectal cancers. Three candidate tumour suppressor genes, DCC, SMAD4 and SMAD2, map to this region. The SMAD4(DPC4) gene was recently identified as a candidate pancreatic cancer suppressor gene. It is also a gene for juvenile polyposis tumour predisposition syndrome. Somatic SMAD4 mutations have been detected in some colorectal carcinomas. However, the frequency of these mutations is relatively low, and whether SMAD4 plays a key role in colorectal tumorigenesis is still unclear. In addition to loss of chromosomal material and intragenic mutations there is a third mechanism, DNA methylation, which may have an important role in gene inactivation. In the present study, we examined whether promoter hypermethylation could be a mechanism for SMAD4 inactivation. In total, 42 colorectal tumours were selected for the methylation analysis and no evidence of promoter hypermethylation was found. Our result suggests that hypermethylation of the SMAD4 promoter region is not a frequent event in colorectal tumorigenesis.

Citing Articles

Dysregulation of transcripts SMAD4-209 and SMAD4-213 and their respective promoters in colon cancer cell lines.

Babic T, Ugrin M, Jeremic S, Kojic M, Dinic J, Banovic Djeri B J Cancer. 2024; 15(15):5118-5131.

PMID: 39132157 PMC: 11310865. DOI: 10.7150/jca.98911.

Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay.

Swellam M, Saad E, Sabry S, Denewer A, Abdel Malak C, Abouzid A J Genet Eng Biotechnol. 2021; 19(1):54.

PMID: 33825073 PMC: 8024427. DOI: 10.1186/s43141-021-00154-x.

Deletion and down-regulation of SMAD4 gene in colorectal cancers in a Chinese population.

Ma Y, Yan F, Li L, Liu L, Sun J Chin J Cancer Res. 2014; 26(5):525-31.

PMID: 25400417 PMC: 4220255. DOI: 10.3978/j.issn.1000-9604.2014.09.02.

SMAD4 promoter hypermethylation in Kashmiri colorectal cancer cases.

Sameer A, Siddiqi M Saudi J Gastroenterol. 2011; 17(4):297.

PMID: 21727743 PMC: 3133994. DOI: 10.4103/1319-3767.82591.

Discovery of SMAD4 promoters, transcription factor binding sites and deletions in juvenile polyposis patients.

Calva D, Dahdaleh F, Woodfield G, Weigel R, Carr J, Chinnathambi S Nucleic Acids Res. 2011; 39(13):5369-78.

PMID: 21421563 PMC: 3141234. DOI: 10.1093/nar/gkr091.

References

Kuismanen S, Holmberg M, Salovaara R, Schweizer P, Aaltonen L, de la Chapelle A . Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. Proc Natl Acad Sci U S A. 1999; 96(22):12661-6. PMC: 23037. DOI: 10.1073/pnas.96.22.12661. View

Koyama M, Ito M, Nagai H, Emi M, Moriyama Y . Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Mutat Res. 1999; 406(2-4):71-7. DOI: 10.1016/s1383-5726(99)00003-5. View

Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M . Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol. 2000; 18(11):2193-200. DOI: 10.1200/JCO.2000.18.11.2193. View

Bird A . CpG-rich islands and the function of DNA methylation. Nature. 1986; 321(6067):209-13. DOI: 10.1038/321209a0. View

Vogelstein B, Fearon E, Hamilton S, Kern S, Preisinger A, Leppert M . Genetic alterations during colorectal-tumor development. N Engl J Med. 1988; 319(9):525-32. DOI: 10.1056/NEJM198809013190901. View

Fearon E, Cho K, Nigro J, Kern S, Simons J, Ruppert J . Identification of a chromosome 18q gene that is altered in colorectal cancers. Science. 1990; 247(4938):49-56. DOI: 10.1126/science.2294591. View

Sakai T, Toguchida J, Ohtani N, Yandell D, Rapaport J, Dryja T . Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet. 1991; 48(5):880-8. PMC: 1683063. View

Konishi M, Fukunari H, Tanaka K, Miyaki M . Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 1992; 52(13):3801-3. View

Cho K, Oliner J, Simons J, Hedrick L, Fearon E, Preisinger A . The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics. 1994; 19(3):525-31. DOI: 10.1006/geno.1994.1102. View

10.

Herman J, Latif F, Weng Y, Lerman M, Zbar B, Liu S . Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A. 1994; 91(21):9700-4. PMC: 44884. DOI: 10.1073/pnas.91.21.9700. View

11.

Laird P, Jaenisch R . DNA methylation and cancer. Hum Mol Genet. 1994; 3 Spec No:1487-95. DOI: 10.1093/hmg/3.suppl_1.1487. View

12.

Hahn S, Schutte M, Hoque A, Moskaluk C, DA COSTA L, Rozenblum E . DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996; 271(5247):350-3. DOI: 10.1126/science.271.5247.350. View

13.

Schutte M, Hruban R, Hedrick L, Cho K, Nadasdy G, Weinstein C . DPC4 gene in various tumor types. Cancer Res. 1996; 56(11):2527-30. View

14.

Thiagalingam S, Lengauer C, Leach F, Schutte M, Hahn S, Overhauser J . Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet. 1996; 13(3):343-6. DOI: 10.1038/ng0796-343. View

15.

Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K . Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer. 1996; 15(4):234-45. DOI: 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2. View

16.

NAGATAKE M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S . Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 1996; 56(12):2718-20. View

17.

Eppert K, Scherer S, Ozcelik H, Pirone R, Hoodless P, Kim H . MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 1996; 86(4):543-52. DOI: 10.1016/s0092-8674(00)80128-2. View

18.

Takagi Y, Kohmura H, Futamura M, Kida H, Tanemura H, Shimokawa K . Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology. 1996; 111(5):1369-72. DOI: 10.1053/gast.1996.v111.pm8898652. View

19.

Rozenblum E, Schutte M, Goggins M, Hahn S, Panzer S, Zahurak M . Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res. 1997; 57(9):1731-4. View

20.

MacGrogan D, Pegram M, Slamon D, Bookstein R . Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene. 1997; 15(9):1111-4. DOI: 10.1038/sj.onc.1201232. View